Notably, VGF CSF levels are chronically downregulated in patients with AD (57, 58) but elevated in pwMS, reflecting the divergent NR4A2 expression in the CNS of patients with AD and MS. The gene discussed is NR4A2; the disease is myeloid sarcoma.